All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …

Genomic analyses promise to improve tumor characterization to optimize personalized
treatment for patients with hepatocellular carcinoma (HCC). Exome sequencing analysis of 243 …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Here, we
performed high-resolution copy-number analysis on 125 HCC tumors and whole-exome …

While it is universally accepted that intact RNA constitutes the best representation of the
steady-state of transcription, there is no gold standard to define RNA quality prior to gene …

Hepatocellular adenomas (HCA) with activated β‐catenin present a high risk of malignant
transformation. To permit robust routine diagnosis to allow for HCA subtype classification, we …

Background & Aims Our increasing understanding of hepatocellular carcinoma (HCC) biology
holds promise for personalized care, however its translation into clinical practice requires …

Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of
inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour …

Hepatocellular carcinomas (HCCs) are liver tumors related to various etiologies, including
alcohol intake and infection with hepatitis B (HBV) or C (HCV) virus. Additional risk factors …

Epigenetic deregulation has emerged as a driver in human malignancies. There is no clear
understanding of the epigenetic alterations in hepatocellular carcinoma (HCC) and of the …

Background & Aims Hepatocellular adenomas (HCAs) are benign liver tumors that can be
assigned to molecular subtypes based on inactivating mutations in hepatocyte nuclear factor …